Literature DB >> 18713996

Synoviocyte innate immune responses: I. Differential regulation of interferon responses and the JNK pathway by MAPK kinases.

Toshio Yoshizawa1, Deepa Hammaker, Susan E Sweeney, David L Boyle, Gary S Firestein.   

Abstract

JNK is a key regulator of matrix metalloproteinase production in rheumatoid arthritis. It is regulated by two upstream kinases known as MKK4 and MKK7. Previous studies demonstrated that only MKK7 is required for cytokine-mediated JNK activation and matrix metalloproteinase expression in cultured fibroblast-like synoviocytes (FLS). However, the functions of MKK4 and MKK7 in synoviocyte innate immune responses have not been determined. TNF, peptidoglycan (PGN), and LPS stimulation led to higher and more prolonged MKK7 phosphorylation compared with MKK4 in FLS. However, this pattern was reversed in poly(I-C) stimulated cells. siRNA knockdown studies showed that TNF, PGN, and LPS-induced JNK and c-Jun phosphorylation are MKK7 dependent, while poly(I-C) responses require both MKK4 and MKK7. Poly(I-C)-induced expression of IP-10, RANTES, and IFN-beta mRNA was decreased in MKK4- or MKK7-deficient FLS. However, MKK4 and MKK7 deficiency did not affect phosphorylation of IkappaB kinase-related kinases in the TLR3 signaling pathway. MKK7, but not MKK4 deficiency, significantly decreased poly(I-C)-mediated IRF3 dimerization, DNA binding, and IFN-sensitive response element-mediated gene transcription. These results were mimicked by the JNK inhibitor SP600125, indicating that JNK can directly phosphorylate IRF3. In contrast, deficiency of either MKK4 or MKK7 decreased AP-1 transcriptional activity. Therefore, JNK is differentially regulated by MKK4 and MKK7 depending on the stimulus. MKK7 is the primary activator of JNK in TNF, LPS, and PGN responses. However, TLR3 requires both MKK4 and MKK7, with the former activating c-Jun and the latter activating both c-Jun and IRF3 through JNK-dependent mechanisms.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18713996      PMCID: PMC2725405          DOI: 10.4049/jimmunol.181.5.3252

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  46 in total

1.  Induction of IRF-3/-7 kinase and NF-kappaB in response to double-stranded RNA and virus infection: common and unique pathways.

Authors:  T Iwamura; M Yoneyama; K Yamaguchi; W Suhara; W Mori; K Shiota; Y Okabe; H Namiki; T Fujita
Journal:  Genes Cells       Date:  2001-04       Impact factor: 1.891

2.  Role of MEKK2-MEK5 in the regulation of TNF-alpha gene expression and MEKK2-MKK7 in the activation of c-Jun N-terminal kinase in mast cells.

Authors:  K Chayama; P J Papst; T P Garrington; J C Pratt; T Ishizuka; S Webb; S Ganiatsas; L I Zon; W Sun; G L Johnson; E W Gelfand
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

3.  Differential requirement of MKK4 and MKK7 in JNK activation by distinct scaffold proteins.

Authors:  Haiying Zou; Qinxi Li; Sheng-Cai Lin; Zhenguo Wu; Jiahuai Han; Zhiyun Ye
Journal:  FEBS Lett       Date:  2006-12-14       Impact factor: 4.124

4.  c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis.

Authors:  Z Han; D L Boyle; L Chang; B Bennett; M Karin; L Yang; A M Manning; G S Firestein
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

5.  MKK7 is an essential component of the JNK signal transduction pathway activated by proinflammatory cytokines.

Authors:  C Tournier; C Dong; T K Turner; S N Jones; R A Flavell; R J Davis
Journal:  Genes Dev       Date:  2001-06-01       Impact factor: 11.361

Review 6.  Ceramide regulates cellular homeostasis via diverse stress signaling pathways.

Authors:  P P Ruvolo
Journal:  Leukemia       Date:  2001-08       Impact factor: 11.528

7.  Activation, differential localization, and regulation of the stress-activated protein kinases, extracellular signal-regulated kinase, c-JUN N-terminal kinase, and p38 mitogen-activated protein kinase, in synovial tissue and cells in rheumatoid arthritis.

Authors:  G Schett; M Tohidast-Akrad; J S Smolen; B J Schmid; C W Steiner; P Bitzan; P Zenz; K Redlich; Q Xu; G Steiner
Journal:  Arthritis Rheum       Date:  2000-11

8.  Identification of distinct signaling pathways leading to the phosphorylation of interferon regulatory factor 3.

Authors:  M J Servant; B ten Oever; C LePage; L Conti; S Gessani; I Julkunen; R Lin; J Hiscott
Journal:  J Biol Chem       Date:  2001-01-05       Impact factor: 5.157

Review 9.  Physiological roles of MKK4 and MKK7: insights from animal models.

Authors:  Xin Wang; Auriane Destrument; Cathy Tournier
Journal:  Biochim Biophys Acta       Date:  2006-11-10

10.  Key differences in TLR3/poly I:C signaling and cytokine induction by human primary cells: a phenomenon absent from murine cell systems.

Authors:  Anna M Lundberg; Stefan K Drexler; Claudia Monaco; Lynn M Williams; Sandra M Sacre; Marc Feldmann; Brian M Foxwell
Journal:  Blood       Date:  2007-07-27       Impact factor: 22.113

View more
  19 in total

1.  Cytokine and catabolic enzyme expression in synovium, synovial fluid and articular cartilage of naturally osteoarthritic equine carpi.

Authors:  J L Kamm; A J Nixon; T H Witte
Journal:  Equine Vet J       Date:  2010-09-14       Impact factor: 2.888

2.  Gadd45beta deficiency in rheumatoid arthritis: enhanced synovitis through JNK signaling.

Authors:  Camilla I Svensson; Tomoyuki Inoue; Deepa Hammaker; Akihisa Fukushima; Salvatore Papa; Guido Franzoso; Georg Schett; Maripat Corr; David L Boyle; Gary S Firestein
Journal:  Arthritis Rheum       Date:  2009-11

3.  Suppression of collagen-induced arthritis in growth arrest and DNA damage-inducible protein 45β-deficient mice.

Authors:  Yubin Luo; David L Boyle; Deepa Hammaker; Meghan Edgar; Guido Franzoso; Gary S Firestein
Journal:  Arthritis Rheum       Date:  2011-10

4.  Targeting interferon regulatory factors to inhibit activation of the type I IFN response: implications for treatment of autoimmune disorders.

Authors:  Susan E Sweeney
Journal:  Cell Immunol       Date:  2011-08-10       Impact factor: 4.868

Review 5.  Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis.

Authors:  Beatrix Bartok; Gary S Firestein
Journal:  Immunol Rev       Date:  2010-01       Impact factor: 12.988

6.  SPA0355, a thiourea analogue, inhibits inflammatory responses and joint destruction in fibroblast-like synoviocytes and mice with collagen-induced arthritis.

Authors:  Y R Lee; J K Hwang; H S Lee; Y J Cheon; J H Ryu; S I Lee; H B Kwak; S M Lee; J S Kim; J W Park; R Jeon; B H Park
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

Review 7.  The role of toll-like receptors in rheumatoid arthritis.

Authors:  Qi-Quan Huang; Richard M Pope
Journal:  Curr Rheumatol Rep       Date:  2009-10       Impact factor: 4.592

8.  Identification of three single nucleotide polymorphisms in Anopheles gambiae immune signaling genes that are associated with natural Plasmodium falciparum infection.

Authors:  Ashley A Horton; Yoosook Lee; Cheick A Coulibaly; Vanessa K Rashbrook; Anthony J Cornel; Gregory C Lanzaro; Shirley Luckhart
Journal:  Malar J       Date:  2010-06-11       Impact factor: 2.979

9.  Effects of inflammatory cytokine IL-27 on the activation of fibroblast-like synoviocytes in rheumatoid arthritis.

Authors:  Chun K Wong; Da P Chen; Lai S Tam; Edmund K Li; Yi B Yin; Christopher W K Lam
Journal:  Arthritis Res Ther       Date:  2010-07-06       Impact factor: 5.156

10.  MicroRNA-206 inhibits influenza A virus replication by targeting tankyrase 2.

Authors:  Gayan Bamunuarachchi; Xiaoyun Yang; Chaoqun Huang; Yurong Liang; Yujie Guo; Lin Liu
Journal:  Cell Microbiol       Date:  2020-11-04       Impact factor: 3.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.